"Spirostans" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cholestane derivatives containing a fused lactone ring at the 16,17-position and a spiroglycosidic linkage at C-22. Members include sarsaponin, DIOSGENIN and yamogenin.
| Descriptor ID |
D013150
|
| MeSH Number(s) |
D04.210.500.247.515
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Spirostans".
Below are MeSH descriptors whose meaning is more specific than "Spirostans".
This graph shows the total number of publications written about "Spirostans" by people in this website by year, and whether "Spirostans" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Spirostans" by people in Profiles.
-
Novel sarsasapogenin-triazolyl hybrids as potential anti-Alzheimer's agents: Design, synthesis and biological evaluation. Eur J Med Chem. 2018 May 10; 151:351-362.
-
Synthesis of new sarsasapogenin derivatives with antiproliferative and apoptotic effects in MCF-7 cells. Steroids. 2018 03; 131:23-31.
-
Effect and mechanism of dioscin from Dioscorea spongiosa on uric acid excretion in animal model of hyperuricemia. J Ethnopharmacol. 2018 Mar 25; 214:29-36.
-
Synthesis and evaluation of 26-amino acid methyl ester substituted sarsasapogenin derivatives as neuroprotective agents for Alzheimer's disease. Steroids. 2017 09; 125:93-106.